一站式玻璃体腔注药模式的建立与管理专家共识  

One-stop intravitreal injection model:expert consensus on establishment and management

作　　者：李筱荣[1] 黎晓新 许迅[4] 

机构地区：[1]天津医科大学眼科医院、天津医科大学眼科研究所、天津医科大学眼视光学院,天津300384 [2]厦门大学附属厦门眼科中心,厦门361003 [3]北京大学人民医院眼科,北京100044 [4]上海交通大学医学院附属第一人民医院眼科、国家眼部疾病临床医学研究中心,上海200080

出　　处：《中华眼底病杂志》2023年第3期187-193,共7页Chinese Journal of Ocular Fundus Diseases

摘　　要：玻璃体腔注药是老年性黄斑变性、糖尿病视网膜病变等常见慢性眼底病的治疗方式。《“十四五”全国眼健康规划(2021-2025年)》提出,需聚焦眼底病等重点眼病,完善慢性眼病患者管理模式。因此,探讨如何在保障患者医疗安全前提下,进一步优化玻璃体腔注药服务流程,以提升医疗服务效率、规范化管理水平及改善患者就医体验,具有一定的意义。遵循《我国视网膜病玻璃体腔注药术质量控制标准》,针对建立一站式玻璃体腔注药模式及其组织管理、标准化操作流程、质量控制与安全管理等环节,我国眼底病及相关领域专家通过认真、全面、充分讨论达成共识性意见,为建立适合我国眼科国情的玻璃体腔注药管理模式、促进我国眼底病诊疗模式的发展,提供更多参考。Intravitreal drug injection is a treatment for common chronic fundus diseases such as age-related macular degeneration and diabetic retinopathy.The“14th Five-Year”National Eye Health Plan(2021-2025)recommends focusing on fundus diseases and improve the management mode of patients with chronic eye diseases.Therefore,it is imperative to explore how to further optimize the service process of intravitreal injection under the premise of guaranteeing patients'medical safety,to promote medical service efficiency and standardized management level and improve the medical experience of patients.Based on the quality control standard of vitreous cavity injection for retinopathy in China,Chinese fundus disease and related field experts developed the present expert consensus on the establishment of a one-stop intravitreal injection model and the management of its organization after a serious,comprehensive,and complete discussion,focusing on a standardized operation process,quality control,and safety management,providing more references for establishing a suitable intravitreal injection management model for ophthalmology and promoting the development of diagnostic and treatment models for fundus disease in China.

关 键 词：玻璃体腔注药 标准化操作流程 组织管理 医师诊疗模式 质量控制标准 专家共识 

分 类 号：R774.5[医药卫生—眼科]